EMMA (EMMA) Stock Price & Analysis
EMMA (EMMA) fell 1.72% to USD 0.06 as of September 8, 2026 at 13:21 UTC, according to Nexqual real-time market data.
EMMA last closed at USD 0.06; the session ranged USD 0.06–0.07 on volume of 18,473 shares. Market capitalization is —, with a 52-week range of USD 0.01–0.09 (OQB). Source: Nexqual, September 8, 2026 at 13:21 UTC.
Key Statistics (as of September 8, 2026 at 13:21 UTC)
| Price | USD 0.06 |
|---|---|
| Change | ▼ 1.72% (down) |
| Previous Close | USD 0.06 |
| Open | USD 0.06 |
| Day Range | USD 0.06 – 0.07 |
| 52-Week Range | USD 0.01 – 0.09 |
| Volume | 18,473 shares |
| Market Cap | — |
| Exchange | OQB |
Technical Analysis (EMMA)
Nexqual's technical model rates EMMA "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 13:21 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 64.62 (neutral) |
| vs SMA50 | Above (USD 0.02) |
| MACD | 0.01 (positive) |
From EMMA's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals, Inc. | USD 15 | ▼ 5.3% |
| MRZM | Marizyme, Inc. | USD 0 | ▲ 0% |
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
| SYBX | Synlogic, Inc. | USD 1.17 | ▼ 4.1% |
| BIXT | Bioxytran, Inc. | USD 0.02 | ▼ 0.47% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:21 UTC. This page is informational and not investment advice.